Comment
doi: 10.1001/jama.2024.12065.
GLP-1 Agonists for Obesity
Affiliations
- PMID: 39083266
- DOI: 10.1001/jama.2024.12065
Item in Clipboard
Comment
GLP-1 Agonists for Obesity
JAMA.
.
No abstract available
Comment in
-
GLP-1 Agonists for Obesity-Reply.JAMA. 2024 Aug 27;332(8):675-676. doi: 10.1001/jama.2024.12077. JAMA. 2024. PMID: 39083314 No abstract available.
Comment on
-
GLP-1 Agonists for Obesity-A New Recipe for Success?JAMA. 2024 Mar 26;331(12):1007-1008. doi: 10.1001/jama.2024.2252. JAMA. 2024. PMID: 38421659
Similar articles
-
GLP-1 Agonists for Obesity.JAMA. 2024 Aug 27;332(8):673. doi: 10.1001/jama.2024.12074. JAMA. 2024. PMID: 39083284 No abstract available.
-
GLP-1 Agonists for Obesity.JAMA. 2024 Aug 27;332(8):672-673. doi: 10.1001/jama.2024.12071. JAMA. 2024. PMID: 39083283 No abstract available.
-
GLP-1 Agonists for Obesity.JAMA. 2024 Aug 27;332(8):673-674. doi: 10.1001/jama.2024.12068. JAMA. 2024. PMID: 39083262 No abstract available.
-
Table: GLP-1 and GIP/GLP-1 receptor agonists for chronic weight management.Med Lett Drugs Ther. 2024 Aug 5;66(1708):e1-e2. doi: 10.58347/tml.2024.1708d. Med Lett Drugs Ther. 2024. PMID: 39137182 Review. No abstract available.
-
Role of glucagon-like peptide 1 receptor agonists in management of obesity.Am J Health Syst Pharm. 2016 Oct 1;73(19):1493-507. doi: 10.2146/ajhp150990. Epub 2016 Aug 12. Am J Health Syst Pharm. 2016. PMID: 27521241 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
